NCT05607732 · RECRUITING
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
This trial is testing a digital screening tool called MyCog, built on the NIH Toolbox, to see whether primary care clinics can reliably catch early cognitive impairment in patients from underserved communities. It is a Phase NA pragmatic trial, meaning researchers are testing whether something works in real-world clinical settings, not a controlled lab environment. The focus is on earlier detection and better follow-up care, not on any drug or treatment.
You may qualify if
- been seen by an Oak Street healthcare provider affiliated with one of the 24 enrolled practices
- had at least one clinic visit (routine or Annual Wellness Visit) during the 3-year study period
- not been diagnosed previously with cognitive deficits, impairments or dementias.
You're excluded if
- Children, adolescence, and younger adults are excluded as cognitive impairment in these populations is often due to differences other than age-related changes.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-03-27